Incidence rates of hepatitis B and C virus infections among blood donors in Hiroshima, Japan, during 10 years from 1994 to 2004

被引:29
作者
Tanaka, Junko [1 ]
Mizui, Masaaki [2 ]
Nagakami, Hideki [2 ]
Katayama, Keiko [1 ]
Tabuchi, Ayako [1 ]
Komiya, Yutaka [1 ]
Miyakawa, Yuzo [3 ]
Yoshizawa, Hiroshi [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Epidemiol Infect Dis Control & Prevent, Minami Ku, Hiroshima 7348551, Japan
[2] Japanese Red Cross Hiroshima Blood Ctr, Dept Lab Med, Hiroshima, Japan
[3] Miyakawa Mem Res Fdn, Tokyo, Japan
关键词
hepatitis B virus; hepatitis C virus; blood donors; incidence;
D O I
10.1159/000118794
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Objective: Although prevalence rates of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections have kept decreasing in blood donors, there is little information on incidence rates of these hepatitis viruses in Japan. Methods: During 10 years from June 1994 through April 2004, 418,269 inhabitants of Hiroshima, Japan, donated blood ( 1,409,465 units in total). They were screened for serum markers of HBV and HCV infections, and individuals who developed de novo infections were identified. Results: Infection with HBV occurred at a rate of 2.78 per 100,000 person-years (95% confidence interval: 1.78-4.14/100,000 person-years) and that with HCV at a rate of 1.86 per 100,000 person-years ( 95% confidence interval: 1.06-3.01/100,000 person-years). Residual risks of transmission by transfusions, based on the relationship risk [ window period ( estimated at 0.15 and 0.03 years in chimpanzees inoculated with minimum infectious doses for HBV and HCV, respectively) x incidence], were 1/243,000 for HBV and 1/1,960,000 for HCV infections. Conclusion: At present, incidence rates of HBV and HCV infections are extremely low in Japan. Copyright (c) 2008 S. Karger AG, Basel.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 20 条
[1]   A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors [J].
Busch, MP ;
Glynn, SA ;
Stramer, SL ;
Strong, DM ;
Caglioti, S ;
Wright, DJ ;
Pappalardo, B ;
Kleinman, SH .
TRANSFUSION, 2005, 45 (02) :254-264
[2]  
Chiavetta JA, 2003, CAN MED ASSOC J, V169, P767
[3]   Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population [J].
Dodd, RY ;
Notari, EP ;
Stramer, SL .
TRANSFUSION, 2002, 42 (08) :975-979
[4]   Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission [J].
Katayama, K ;
Kumagai, J ;
Komiya, Y ;
Mizui, M ;
Yugi, H ;
Kishimoto, S ;
Yamanaka, R ;
Tamatsukuri, S ;
Tomoguri, T ;
Miyakawa, Y ;
Tanaka, J ;
Yoshizawa, H .
INTERVIROLOGY, 2004, 47 (01) :57-64
[5]   Virological outcomes in patients infected chronically with hepatitis B virus genotype A in comparison with genotypes B and C [J].
Kobayashi, M ;
Akuta, N ;
Suzuki, F ;
Suzuki, Y ;
Arase, Y ;
Ikeda, K ;
Hosaka, T ;
Saitoh, S ;
Kobayashi, M ;
Someya, T ;
Sato, J ;
Watabiki, S ;
Miyakawa, Y ;
Kumada, H .
JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (01) :60-67
[6]   Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection of adulthood in japan [J].
Kobayashi, M ;
Arase, Y ;
Ikeda, K ;
Tsubota, A ;
Suzuki, Y ;
Saitoh, S ;
Kobayashi, M ;
Suzuki, F ;
Akuta, N ;
Someya, T ;
Matsuda, M ;
Sato, J ;
Takagi, K ;
Miyakawa, Y ;
Kumada, H .
JOURNAL OF MEDICAL VIROLOGY, 2002, 68 (04) :522-528
[7]  
KOMIYA Y, 2008, IN PRESS TRANSFUSION
[8]  
NOTO H, 1994, J GASTROEN HEPATOL, V18, P943
[9]  
OKAMOTO H, 1990, JPN J EXP MED, V60, P215
[10]  
Sasaki F, 1996, J Epidemiol, V6, P198